دورية أكاديمية

Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer

التفاصيل البيبلوغرافية
العنوان: Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer
المؤلفون: Puglisi, F. *, Cardellino, G.G., Crivellari, D., Di Loreto, C., Magri, M.D., Minisini, A.M., Mansutti, M., Andreetta, C., Russo, S., Lombardi, D., Perin, T., Damante, G., Veronesi, A.
المصدر: In Annals of Oncology September 2008 19(9):1541-1546
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdn165